佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

查看: 1372|回复: 5

【CENGILD 0243 交流专区】

[复制链接]
发表于 30-3-2022 11:22 PM | 显示全部楼层 |阅读模式
本帖最后由 icy97 于 21-5-2024 01:26 AM 编辑

(吉隆坡30日讯)以诊治肠胃、肝脏疾病,和肥胖为主的医疗中心–Cengild医疗有限公司今日推介首次公开售股(IPO)招股书,将公开发售2亿1800万股新股,筹措最多7220万令吉来扩建医疗中心、兴建2家肠胃、肝脏疾病与肥胖治疗专科医院,以及作为营运资本。

Cengild医疗的IPO申请将在4月5日截止,并预期在4月18日上市。

配合上市计划,Cengild医疗拟发售2亿1880万股,每股发售价33仙的新股,其中1628万6000股将透过市场询价方式(Book Building)发售予机构和特定投资者、4094万股供大马公众认购,剩余1500万股则供合格定时、主要高级管理层、雇员和有功人士认购。

Cengild医疗拟透过IPO筹资最多7220万令吉,在扣除470万令吉上市费用后,1300令吉将用于扩建现位于[email protected] South的医疗中心、3710万令吉用作在新山、槟城或怡保兴建2家肠胃与肝脏疾病,以及肥胖治疗的专科医院,剩余1740万令吉作为营运资本。

Cengild医疗执行主席拿督陈学瑜医生透过文告表示:“我们在2017年创立Cengild医疗,目标是建设大马卓越的肠胃、肝脏疾病及肥胖治疗中心。我们希望透过一站式专科谘询来为客户提供专业的医疗服务。在过去4年半时间,我们已吸引约6万7000名病患造访,并进行超过2万1000次内窥镜检查和逾3500次手术。”

他补充,从2018至2021财政年,Cengild医疗营业额从1168万令吉增至6347万令吉,复合年均增长率(CAGR)达到75.81%。

“在考量人口增长、人口老化和国人健康意识的提高,我们预期医疗保健服务需求将持续增加。”

目前,Cengild医疗是全马唯一一家专攻肠胃、肝脏疾病及肥胖治疗的全方位医疗中心,而其位于[email protected] South的医疗中心设有10家诊所、3间内窥镜室、21张病床、特诊科等设备。

丰隆投资银行将是Cengild医疗IPO计划的首要顾问、保荐人、独家包销商和承销商。
回复

使用道具 举报


ADVERTISEMENT

 楼主| 发表于 19-4-2022 11:25 AM | 显示全部楼层

陈学瑜(左三)在众董事和投行代表陪同下主持上市仪式。
(吉隆坡18日讯)CENGILD医疗(CENGILD,0243,创业板医疗保健组)粉墨登场,表现亮眼,首宗交易报49.5仙,之后最高报51仙,溢价18仙或54.55%。

该股闭市报46.5仙,全日共溢价13.5仙或40.91%,为第二最热门股,成交量1亿6280万900股。

该公司执行主席拿督陈学瑜医生今在上市仪式上表示,“此次IPO为我们提供了实现我们的雄心壮志并加速我们的扩张计划的平台。”

“作为马来西亚唯一一家专注于肠胃和肝脏疾病以及肥胖症的独立全面医疗中心,我们的目标不仅是为我们的患者提供最好的治疗,而且还要在本区域建立一个受推崇的卓越中心。”

他表示,“Cengild的团队在过去取得了令人印象深刻和出色的成绩,随着IPO后的扩张,我相信我们将会攀上更高峰。对我们来说,这只是新征程的开始,我们放眼接下来取得更多的成功。”

CENGILD医疗新股发售价为33仙,相等于上市时市值2亿7020万令吉。该公司的IPO共获得44.53倍超额认购率,显示吸引到强大购兴。

展望未来,该公司预期2022至2026年复合盈利年均成长率达到9.6%。

该公司从上市行动中筹集7220万令吉,其中1300万令吉用作吉隆坡现有医疗中心的扩张计划,以及3710万令吉用扩张至其他主要城市,例如新山、槟城或怡保。
回复

使用道具 举报

发表于 21-5-2024 01:27 AM | 显示全部楼层
CENGILD MEDICAL BERHAD

Date of change
22 Apr 2024
Name
MR MICHEAL BONG ENN CHUNG @ MICHEAL WONG ENN CHUNG
Age
52
Gender
Male
Nationality
Malaysia
Type of change
Resignation
Designation
Chief Executive Officer
Reason
To pursue other interests.




Date of change
22 Apr 2024
Name
MISS YAP SOH KIM
Age
60
Gender
Female
Nationality
Malaysia
Type of change
Appointment
Designation
Others
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
1
Professional Qualification
Certificate of Private Secretarialship
Stamford College, Malaysia
  
Working experience and occupation
-1983 to 1996: MUI Bank Berhad (now known as Hong Leong Bank Berhad)                        last position held was Confidential Secretary- 1996 to 2010: Subang Jaya Medical Centre Sdn Bhd                         last position held was Manager (Front Office)- 2011 to 2017: Sunway Medical Centre Sdn Bhd                         last position held was Assistant Director (Business Office)- 2017 to 2023: Cengild Sdn Bhd                         last position held was Chief Executive Officer
Directorships in public companies and listed issuers (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Nil


Remarks :
Appointed as the Acting Chief Executive Officer


回复

使用道具 举报

发表于 8-9-2024 02:23 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2024
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2024
30 Jun 2023
30 Jun 2024
30 Jun 2023
$$'000
$$'000
$$'000
$$'000
1Revenue
16,145
15,771
66,854
70,280
2Profit/(loss) before tax
2,705
2,666
15,850
17,374
3Profit/(loss) for the period
1,521
2,236
11,085
13,288
4Profit/(loss) attributable to ordinary equity holders of the parent
1,521
2,236
11,085
13,288
5Basic earnings/(loss) per share (Subunit)
0.18
0.27
1.33
1.62
6Proposed/Declared dividend per share (Subunit)
0.37
0.00
0.74
0.37


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1337
0.1296

回复

使用道具 举报

发表于 8-9-2024 02:25 AM | 显示全部楼层
CENGILD MEDICAL BERHAD

Entitlement subject
Interim Dividend
Entitlement description
Single tier interim dividend of 0.37 sen per share for the financial year ended 30 June 2024
Ex-Date
10 Sep 2024
Entitlement date
11 Sep 2024
Entitlement time
5:00 PM
Financial Year End
30 Jun 2024
Period

Share transfer book & register of members will be
to  closed from (both dates inclusive) for the purpose of determining the entitlement
Payment Date
27 Sep 2024
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers
11 Sep 2024
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit

c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)

Entitlement indicator
Currency
Announced Currency
Malaysian Ringgit (MYR)
Disbursed Currency
Malaysian Ringgit (MYR)
Entitlement in Currency
Malaysian Ringgit (MYR) 0.0037

回复

使用道具 举报

发表于 20-9-2024 02:52 AM | 显示全部楼层
CENGILD MEDICAL BERHAD

Date of change
10 Sep 2024
Name
MR JOHN LIAN YOON AHN
Age
37
Gender
Male
Nationality
Malaysia
Type of change
Appointment
Designation
Others
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
1
Professional Qualification
Fellow Member of Association of Chartered Certified Accountants (FCCA)
Association of Chartered Certified Accountants
2
Professional Qualification
Member of Association of Chartered Certified Accountants (ACCA)
Association of Chartered Certified Accountants
3
Professional Qualification
Member of Malaysian Institute of Accountants (MIA)
Malaysian Institute of Accountants
4
Professional Qualification
Affiliate of Association of Chartered Certified Accountants (ACCA)
Association of Chartered Certified Accountants
5
Professional Qualification
Student of Association of Chartered Certified Accountants (ACCA)
Association of Chartered Certified Accountants
  
Working experience and occupation
- 2008 to 2012: Shell Business Service Centre Sdn Bhd                         last position held was Internal Auditor- 2012 to 2013: Cypark Resources Berhad                         last position held was Group Accountant- 2013 to 2016: Schlumberger Business Support Hub Sdn Bhd                         last position held was Management Accountant- 2016 to 2020: Pall Malaysia Sdn Bhd                          last position held was Country Finance Manager- 2020 to 2024: HealthMetrics Sdn Bhd                          last position held was Vice President of Finance
Directorships in public companies and listed issuers (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Nil


Remarks :
Appointed as a Financial Controller


回复

使用道具 举报

Follow Us
您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 14-12-2024 07:16 AM , Processed in 0.103221 second(s), 24 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表